Ralington Pharma LLP
About Ralington Pharma LLP
Data last updated:
Ralington Pharma LLP is a limited liability partnership (LLP) based in Sanand, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAE-0673. Its GSTIN is 24AASFR5719H1ZT (Gujarat).
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Kartik Harshad Barot and Smita Kartik Barot.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Sanand, Gujarat.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹3.65 Cr. For the same year it recorded a net profit of ₹2.96 Lakh (net margin 0.8%) and EBITDA of -₹2.45 Lakh (EBITDA margin -0.7%). Revenue has grown at a compounded annual rate (CAGR) of 77% over three years and 113% over five years.
The LLP is associated with 1 brand: Ralington Pharma. Court records list 1 case involving the LLP, including 1 filed against it.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No 32 And 33 Sunshine Industrial Estate, Navapura Changodhar, Sanand, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Ralington Pharma LLP FY 2025 filings available
Ralington Pharma LLP reported revenue of ₹3.65 Cr for FY 2023.
Compounded Annual Growth Rate (CAGR) of Ralington Pharma LLP
Revenue has grown at a compounded annual rate (CAGR) of 113% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ralington Pharma LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹2.96 Lakh | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ralington Pharma LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Ralington Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ralington Pharma LLP
Ralington Pharma LLP is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ralington Pharma LLP this company | ₹3.65 Cr (FY 2023) | •••• | •••• | •••• | Sanand, Gujarat, India | |
| Shubh Pharma Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | -43.0% | •••• | Thane, Maharashtra, India |
| Venova Pharmaceuticals Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Sitnez Biocare Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| Seegakula Pharmaceuticals Private Limited | ₹3.07 Cr (FY 2022) | •••• | •••• | 11.0% | •••• | Bengaluru, Karnataka, India |
| Medrexcare Pharma Private Limited | ₹3.06 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Alisier Drugs Private Limited | ₹3.06 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Ambala Cantt, Haryana, India |
| Verdeus Naturals Private Limited | ₹3.05 Cr (FY 2025) | •••• | •••• | •••• | Mysore, Karnataka, India | |
| Teblik Drugs Private Limited | ₹3.05 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Indore, Madhya Pradesh, India |
| Nway Biotech Private Limited | ₹3.04 Cr (FY 2025) | •••• | •••• | 141.0% | •••• | Aurangabad, Maharashtra, India |
| Vetgrow Pharma Private Limited | ₹3.04 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Ralington Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Designated Partners of Ralington Pharma LLP
Ralington Pharma has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kartik Harshad Barot | Designated Partner | 01 Jun 2015 | 11 Years 4 Months | Current |
| Smita Kartik Barot | Designated Partner | 02 Apr 2024 | 2 Years 6 Months | Current |
Ownership and Shareholding of Ralington Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ralington Pharma LLP
Ralington Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Ralington Pharma LLP
Ralington Pharma LLP has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Merck Sharp and Dohme Corp & Anr | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Ralington Pharma LLP
Ralington Pharma operates one associated brand: Ralington Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality active pharmaceutical ingredients and intermediates. | ralingtonpharma.com |
Employees and EPFO Compliance at Ralington Pharma LLP
Employment history and EPFO contributions of people linked to Ralington Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ralington Pharma LLP
Ralington Pharma LLP has 4 designated partner changes on record since 2015: 3 appointments and 1 cessation. The latest: Dipesh Ramjibhai Gadhavi ceased to be Designated Partner on 02 Apr 2024.
Credit Ratings, Litigation & Regulatory Alerts for Ralington Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ralington Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ralington Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ralington Pharma LLP
Ralington Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AASFR5719H1ZT | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ralington Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ralington Pharma LLP
Ralington Pharma is an active limited liability partnership based in Sanand, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 2015 (11+ years old) and is registered under LLPIN AAE-0673.
Ralington Pharma reported revenue of ₹3.65 Cr for FY 2023.
Ralington Pharma has 2 current designated partners:
- Kartik Harshad Barot - Designated Partner
- Smita Kartik Barot - Designated Partner
Ralington Pharma reported a net profit of ₹2.96 Lakh (net margin 0.8%) and EBITDA of -₹2.45 Lakh (EBITDA margin -0.7%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ralington Pharma is 77% over three years and 113% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ralington Pharma is 24AASFR5719H1ZT, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Ralington Pharma is AAE-0673. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Ralington Pharma has 1 court case on record: 1 filed against it.
Ralington Pharma was incorporated on 01 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Ralington Pharma by revenue are Shubh Pharma Private Limited, Venova Pharmaceuticals Private Limited, Sitnez Biocare Private Limited, Seegakula Pharmaceuticals Private Limited, Medrexcare Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Dipesh Ramjibhai Gadhavi ceased to be Designated Partner on 02 Apr 2024. Smita Kartik Barot was appointed as Designated Partner on 02 Apr 2024. Dipesh Ramjibhai Gadhavi was appointed as Designated Partner on 01 Jun 2015. Ralington Pharma has 4 designated partner changes on record in total.